Pura Vida Investments’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Pura Vida Investments’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-114,945	Closed	-$1.12M	–	294
2021 Q4	$1.12M	Buy	114,945 +64,945	+130%	+$1.22M	0.04%	173
2021 Q3	$1.7M	Buy	+50,000	New	+$1.6M	0.05%	198
2019 Q4	–	Sell	-41,000	Closed	-$1.39M	–	127
2019 Q3	$1.39M	Buy	+41,000	New	+$1.21M	0.24%	74
2018 Q1	–	Sell	-68,154	Closed	-$1.54M	–	98
2017 Q4	$1.54M	Sell	68,154 -1,846	-3%	-$36.1K	0.65%	50
2017 Q3	$1.33M	Buy	+70,000	New	+$1.28M	0.39%	63

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pura Vida Investments's DCPH Position: Q1 2022 in Review

Pura Vida Investments sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 114,945 shares — an estimated $1.12M sold.

Pura Vida Investments first reported a position in DCPH in Q3 2017 and held it in 5 quarters. The position peaked at $1.7M in Q3 2021. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Pura Vida Investments reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Pura Vida Investments sold 114,945 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $1.12M.
Pura Vida Investments first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
Pura Vida Investments's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.7M in Q3 2021.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.